Nielsen B - Search Results

1

Rituximab as first-line treatment for the management of adult patients with non-severe hemophilia A and inhibitors.

Lim MY, Nielsen B, Lee K, Kasthuri RS, Key NS, Ma AD. Lim MY, et al. Among authors: nielsen b. J Thromb Haemost. 2014 Jun;12(6):897-901. doi: 10.1111/jth.12579. J Thromb Haemost. 2014. PMID: 24702722 Free article.

2

Clinical features and management of haemophilic pseudotumours: a single US centre experience over a 30-year period.

Lim MY, Nielsen B, Ma A, Key NS. Lim MY, et al. Among authors: nielsen b. Haemophilia. 2014 Jan;20(1):e58-62. doi: 10.1111/hae.12295. Epub 2013 Oct 31. Haemophilia. 2014. PMID: 24354486

3

Factor VIII inhibitory antibody in a patient with combined factor V/factor VIII deficiency.

Buckner TW, Nielsen BI, Key NS, Ma A. Buckner TW, et al. Among authors: nielsen bi. Haemophilia. 2015 Jan;21(1):e77-80. doi: 10.1111/hae.12557. Epub 2014 Dec 4. Haemophilia. 2015. PMID: 25472918 No abstract available.

4

DDAVP trial in discrepant non-severe haemophilia A patients.

Okoye HC, Nielsen BI, Lee K, Abajas YL, Key NS, Rollins-Raval MA. Okoye HC, et al. Among authors: nielsen bi. Haemophilia. 2018 May;24(3):e152-e154. doi: 10.1111/hae.13485. Epub 2018 May 6. Haemophilia. 2018. PMID: 29732646 No abstract available.

5

Cluster of inhibitors among adult inpatients with haemophilia in a single institution.

Ishaku NG, Key NS, Miller CH, Nielsen B, Buckner T, Chen SL, Hooper WC, Soucie JM. Ishaku NG, et al. Among authors: nielsen b. Haemophilia. 2015 Jul;21(4):e325-8. doi: 10.1111/hae.12697. Epub 2015 May 4. Haemophilia. 2015. PMID: 25939561 No abstract available.

6

Excessive breakthrough bleeding in haemophilia B patients on factor IX-albumin fusion protein prophylactic therapy: A single centre case series.

Kleiboer B, Nielsen B, Ma AD, Abajas Y, Monroe DM, Key NS. Kleiboer B, et al. Among authors: nielsen b. Haemophilia. 2020 Jan;26(1):e23-e25. doi: 10.1111/hae.13896. Epub 2019 Nov 27. Haemophilia. 2020. PMID: 31778004 Free PMC article. No abstract available.

7

Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency.

Nuzzo F, Bulato C, Nielsen BI, Lee K, Wielders SJ, Simioni P, Key NS, Castoldi E. Nuzzo F, et al. Among authors: nielsen bi. Haemophilia. 2015 Mar;21(2):241-248. doi: 10.1111/hae.12554. Epub 2014 Dec 3. Haemophilia. 2015. PMID: 25470420

8

Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.

Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM, Konkle BA; HTCN Study Investigators. Metjian AD, et al. Haemophilia. 2009 Jul;15(4):918-25. doi: 10.1111/j.1365-2516.2009.02025.x. Epub 2009 Apr 7. Haemophilia. 2009. PMID: 19473418

9

Recombinant factor IX.

White GC 2nd, Beebe A, Nielsen B. White GC 2nd, et al. Among authors: nielsen b. Thromb Haemost. 1997 Jul;78(1):261-5. Thromb Haemost. 1997. PMID: 9198163 Review.

10

Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?

White GC 2nd, Kempton CL, Grimsley A, Nielsen B, Roberts HR. White GC 2nd, et al. Among authors: nielsen b. J Thromb Haemost. 2005 Aug;3(8):1676-81. doi: 10.1111/j.1538-7836.2005.01375.x. J Thromb Haemost. 2005. PMID: 16102033 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,723 results

Search Page